Correlation Between Novo Nordisk and NervGen Pharma
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and NervGen Pharma Corp, you can compare the effects of market volatilities on Novo Nordisk and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and NervGen Pharma.
Diversification Opportunities for Novo Nordisk and NervGen Pharma
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novo and NervGen is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and NervGen Pharma go up and down completely randomly.
Pair Corralation between Novo Nordisk and NervGen Pharma
Assuming the 90 days horizon Novo Nordisk is expected to generate 2.9 times less return on investment than NervGen Pharma. But when comparing it to its historical volatility, Novo Nordisk AS is 2.04 times less risky than NervGen Pharma. It trades about 0.03 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 140.00 in NervGen Pharma Corp on August 25, 2024 and sell it today you would earn a total of 45.00 from holding NervGen Pharma Corp or generate 32.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. NervGen Pharma Corp
Performance |
| Timeline |
| Novo Nordisk AS |
| NervGen Pharma Corp |
Novo Nordisk and NervGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and NervGen Pharma
The main advantage of trading using opposite Novo Nordisk and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.The idea behind Novo Nordisk AS and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |